Getinge Management

Management criteria checks 3/4

Getinge's CEO is Mattias Perjos, appointed in Mar 2017, has a tenure of 7.25 years. total yearly compensation is SEK46.39M, comprised of 55.9% salary and 44.1% bonuses, including company stock and options. directly owns 0.029% of the company’s shares, worth €1.28M. The average tenure of the management team and the board of directors is 4.6 years and 7.3 years respectively.

Key information

Mattias Perjos

Chief executive officer

SEK 46.4m

Total compensation

CEO salary percentage	55.9%
CEO tenure	7.3yrs
CEO ownership	0.03%
Management average tenure	4.6yrs
Board average tenure	7.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Mattias Perjos's remuneration changed compared to Getinge's earnings?
Date	Total Compensation	Salary	Company Earnings
Mar 31 2024	n/a	n/a	SEK 2b
Dec 31 2023	SEK 46m	SEK 26m	SEK 2b
Sep 30 2023	n/a	n/a	SEK 2b
Jun 30 2023	n/a	n/a	SEK 2b
Mar 31 2023	n/a	n/a	SEK 3b
Dec 31 2022	SEK 43m	SEK 24m	SEK 2b
Sep 30 2022	n/a	n/a	SEK 3b
Jun 30 2022	n/a	n/a	SEK 3b
Mar 31 2022	n/a	n/a	SEK 3b
Dec 31 2021	SEK 60m	SEK 23m	SEK 3b
Sep 30 2021	n/a	n/a	SEK 3b
Jun 30 2021	n/a	n/a	SEK 4b
Mar 31 2021	n/a	n/a	SEK 4b
Dec 31 2020	SEK 67m	SEK 23m	SEK 3b
Sep 30 2020	n/a	n/a	SEK 3b
Jun 30 2020	n/a	n/a	SEK 2b
Mar 31 2020	n/a	n/a	SEK 1b
Dec 31 2019	SEK 46m	SEK 22m	SEK 1b
Sep 30 2019	n/a	n/a	SEK 1b
Jun 30 2019	n/a	n/a	-SEK 632m
Mar 31 2019	n/a	n/a	-SEK 654m
Dec 31 2018	SEK 34m	SEK 21m	-SEK 967m
Sep 30 2018	n/a	n/a	-SEK 727m
Jun 30 2018	n/a	n/a	SEK 847m
Mar 31 2018	n/a	n/a	SEK 676m
Dec 31 2017	SEK 26m	SEK 15m	SEK 1b

Compensation vs Market: Mattias's total compensation ($USD4.38M) is above average for companies of similar size in the German market ($USD2.26M).

Compensation vs Earnings: Mattias's compensation has been consistent with company performance over the past year.

CEO

Mattias Perjos (52 yo)

7.3yrs

Tenure

SEK 46,388,000

Compensation

Mr. Mattias Perjos, M. Sc., serves as Independent Director at Euroapi S. A. since January 11, 2023. He has been the Chief Executive Officer and President at Getinge AB since March 27, 2017. Mr. Perjos serv...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Mattias Perjos	CEO, President & Director	7.3yrs	SEK 46.39m	0.029% SEK 1.3m
Agneta Palmer	Chief Financial Officer	less than a year	no data	no data
Lars Mattsson	Head of Investor Relations	no data	no data	no data
Anna Romberg	Executive Vice President of Sustainability	3.7yrs	no data	0.0020% SEK 88.0k
Magnus Lundback	Executive Vice President of Human Resources	7.4yrs	no data	0.0014% SEK 61.4k
Carsten Blecker	Chief Commercial Officer	6.5yrs	no data	0.0018% SEK 80.2k
Stephane Roy	President of Surgical Workflows	5.6yrs	no data	0.0014% SEK 61.0k
Eric Honroth	President of Life Science	no data	no data	0.000060% SEK 2.6k
Patricia Fitch	President of North America Region	2.2yrs	no data	no data
Elin Frostehav	President of Acute Care Therapies	2.2yrs	no data	0.00032% SEK 13.9k
Joanna Engelke	Executive VP of Quality Compliance	1.7yrs	no data	no data
Avril Forde	President of Maquet Ltd & Maquet Ireland	8.4yrs	no data	no data

4.6yrs

Average Tenure

52yo

Average Age

Experienced Management: GTN's management team is considered experienced (4.6 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Mattias Perjos	CEO, President & Director	7.3yrs	SEK 46.39m	0.029% SEK 1.3m
Johan Bygge	Independent Director	17.2yrs	SEK 972.90k	0.0058% SEK 250.9k
Carl Bennet	Non-Independent Vice Chairman	35.4yrs	SEK 781.43k	no data
Malin Persson	Independent Director	10.4yrs	SEK 781.43k	0.0030% SEK 129.8k
Johan Malmquist	Independent Chairman	8.3yrs	SEK 1.73m	0.037% SEK 1.6m
Cecilia Wennborg	Independent Director	14.2yrs	SEK 969.80k	0.0029% SEK 128.1k
Ake Larsson	Employee Representative Director	1.7yrs	no data	no data
Dan Frohm	Non-Independent Director	7.3yrs	SEK 928.40k	0.055% SEK 2.4m
Fredrik Brattborn	Employee Representative Director	2.2yrs	no data	no data
Kristian Samuelsson	Independent Director	3.2yrs	SEK 819.72k	no data
Pontus Kall	Deputy Director	no data	no data	no data
Ida Gustafsson	Deputy Director	1.7yrs	no data	0.000020% SEK 871.2

7.3yrs

Average Tenure

54yo

Average Age

Experienced Board: GTN's board of directors are considered experienced (7.3 years average tenure).

Getinge Management

Management criteria checks 3/4

Key information

Recent management updates

Getinge Announces CFO Changes

Getinge AB (Publ) Announces Resignation of Jeanette Hedén Carlsson as Executive Vice President Brand & Communication, Effective December 31, 2023

Getinge AB (Publ) Announces Executive Changes

Getinge AB (Publ) Appoints Joanna Engelke as New Executive Vice President Quality Compliance, Regulatory & Medical Affairs and Member of the Getinge Executive Team

Getinge Appoints Agneta Palmér as Executive Vice President Operational Services Member of the Getinge Executive Team

Lena Hagman to Leave Getinge AB (publ) as Executive Vice President Quality Compliance, Regulatory & Medical Affairs

Recent updates

Investor sentiment deteriorates as stock falls 17%

Getinge AB (publ) Declares A Dividend, Payable on 29 April 2024

Upcoming dividend of kr4.40 per share

Full year 2023 earnings released: EPS: kr8.86 (vs kr9.15 in FY 2022)

Getinge AB (publ) to Report Fiscal Year 2024 Results on Jan 28, 2025

Dividend of kr4.40 announced

Getinge AB (publ) to Report Fiscal Year 2023 Final Results on Mar 27, 2024

Getinge AB (Publ) Proposes Dividend, Payable on April 29, 2024

Getinge Takes A Leap Forward in Cardiovascular Surgery with the 510(k) Clearance for Vasoview Hemopro 3

Full year 2023 earnings released: EPS: kr8.86 (vs kr9.15 in FY 2022)

Getinge AB (Publ) Provides Sales Guidance for the Year 2024

Getinge Announces CFO Changes

Third quarter 2023 earnings released

Getinge AB (publ) (OM:GETI B) acquired Healthmark Industries Company, Inc. for $320 million.

Getinge AB (Publ) Announces Resignation of Jeanette Hedén Carlsson as Executive Vice President Brand & Communication, Effective December 31, 2023

Second quarter 2023 earnings released

Getinge Receives US FDA 510(K) Clearance for Servo-Air® Lite

Investor sentiment deteriorates as stock falls 16%

Getinge AB (publ) (OM:GETI B) entered into an agreement to acquire High Purity New England Inc. for approximately $290 million.

First quarter 2023 earnings released

Now 23% undervalued

Upcoming dividend of kr4.25 per share at 1.6% yield

Getinge Provides Financial Guidance for the First Half, Second Half and Full Year of 2023

Full year 2022 earnings released: EPS: kr9.15 (vs kr10.90 in FY 2021)

Getinge AB (Publ) Proposes Dividend

U.S. Food and Drug Administration Broadens the Consent Decree with Getinge and Includes Its Subsidiary Datascope

Third quarter 2022 earnings released

Getinge AB (publ) Provides Sales Guidance for the Full Year 2022

Getinge AB (Publ) Announces Executive Changes

Getinge AB (Publ) Appoints Joanna Engelke as New Executive Vice President Quality Compliance, Regulatory & Medical Affairs and Member of the Getinge Executive Team

Second quarter 2022 earnings released: EPS: kr2.21 (vs kr2.93 in 2Q 2021)

Getinge AB (Publ) Announces Medical Device Field Action of Hls Set Advanced Products

Getinge Appoints Agneta Palmér as Executive Vice President Operational Services Member of the Getinge Executive Team

Getinge AB (publ) to Report Q2, 2022 Results on Jul 19, 2022

Lena Hagman to Leave Getinge AB (publ) as Executive Vice President Quality Compliance, Regulatory & Medical Affairs

Investor sentiment deteriorated over the past week

Getinge Revises Net Sales Guidance for the Full Year 2022

Independent Chairman recently bought €281k worth of stock

Insufficient new directors

Getinge AB (publ) Declares Dividend for 2021, Payable on May 3, 2022

Upcoming dividend of kr4.00 per share

Getinge AB (publ) to Report Q1, 2022 Results on Apr 26, 2022

Full year 2021 earnings released: EPS: kr10.90 (vs kr11.89 in FY 2020)

Insufficient new directors

Getinge AB to Report Q4, 2022 Results on Feb 01, 2023

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Getinge AB to Report Q4, 2022 Results on Feb 01, 2023

Getinge AB (OM:GETI B) acquired Talis Clinical, LLC for approximately SEK 600 million.

Chief Commercial Officer recently bought €56k worth of stock

Third quarter 2021 earnings released

Second quarter 2021 earnings released: EPS kr2.93 (vs kr1.81 in 2Q 2020)

Getinge AB Provides Sales Guidance for the Year 2021

Getinge's New Torin Artificial Intelligence Solution Improves Hospital Efficiency

Chief Commercial Officer recently bought €27k worth of stock

Chief Commercial Officer recently bought €27k worth of stock

First quarter 2021 earnings released: EPS kr2.36 (vs kr0.99 in 1Q 2020)

Director has left the company

Upcoming dividend of kr3.00 per share

Full year 2020 earnings released: EPS kr11.89 (vs kr4.49 in FY 2019)

Getinge AB Proposes Dividend, Payable on April 27, 2021

Getinge AB and University of Gothenburg Initiates Strategic Research Partnership

New 90-day high: €22.23

Getinge AB Proposes Executive Changes

Full year 2020 earnings released: EPS kr11.89 (vs kr4.49 in FY 2019)

Revenue misses expectations

New 90-day high: €19.57

Getinge Is Announcing A Recall of HLS Set Advanced Products

Getinge AB Provides No Guidance for the Fourth Quarter of 2020 and for Year 2021

Getinge Not to Present Outlook for the Full Year 2020